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ABSTRACT 
The ‘cascade of care’ construct is increasingly used in public health to map the trajectory of local HIV 
epidemics and of different HIV populations. The notion of ‘patient engagement’ is key to the 
progress of people living with HIV through the various ‘steps’ of the cascade as currently 
conceptualised. The public health literature on the definition, measurement, and interpretation of 
cascade of care frameworks is growing in parallel with critical social science literature analysing 
patient engagement through the lenses of ‘patient citizenship’ theories. In this paper, we review 
qualitative literature on HIV treatment, adherence to antiretroviral therapy, and care engagement 
that draws upon the interlinked concepts of therapeutic and biological citizenship. We aim to offer a 
critique of the cascade of care construct using empirical data from research studies published since 
2005 that were influenced by these two concepts. In so doing, the paper places public health 
literature on the cascade of care in dialogue with in-depth qualitative and ethnographic approaches, 
to unpack the understandings and processes shaping patient engagement in HIV treatment and care 
in different settings. The paper also examines the contributions and limitations of the concepts of 
biological and therapeutic citizenship as argued by a number of scholars here reviewed.  
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INTRODUCTION 
The HIV treatment ‘cascade of care’ envisages ‘treated HIV’ as the end point of a process of 
sequential care engagements – from HIV testing, to diagnosis, to linkage and access to antiretroviral 
treatment (ART), to retention in treatment – sufficient to bring about viral suppression (Mugavero, 
Amico, Horn and Thompson, 2013). The cascade creates a framework for generating step-wise 
estimates of intervention access, coverage, adherence, retention, and outcome at national and 
regional level (Kozak, Zinski, Leeper, Willig and Mugavero, 2013; MacCarthy et al., 2015). Such a 
framework provides an overview of key indicators (diagnosed and undiagnosed infections; numbers 
on or off treatment) and their public health implications, and offers a surveillance grid for 
monitoring patient dis/engagement through the pathways of care. The cascade construct thus tends 
to define HIV care (and its success or failure) narrowly in relation to the ultimate benchmark of viral 
suppression, resulting from patients being sufficiently and appropriately engaged through each of its 
steps. 
With ‘treated HIV’ dependent upon patient engagement, HIV treatment is inevitably a political 
process. Discourses of the care cascade imply certain kinds of patient expectation and responsibility. 
An extensive body of extant literature accentuates how social and environmental factors shape HIV 
treatment provision and engagement (Gari et al., 2013; Merten et al., 2010; Underwood, 
Hendrickson, Van Lith, Kunda, and Mallalieu, 2014). Additionally, critical perspectives in the social 
sciences have reflected upon HIV and its care as constituted through situated health practices, 
identities and subjectivities, with implications for different social and political contexts (Doyal, 2013; 
Whyte, 2009). 
Much of this empirical work is qualitative in orientation and has focused on: experiential accounts of 
life with HIV (often contrasted to ‘biomedical’ articulations) (e.g. Davis, Frankis and Flowers, 2006; 
Persson, 2013); the ‘identity’ work involved in reconstructing life around an HIV diagnosis and 
related treatment (e.g. Baumgartner and David, 2009; Flowers, Davis, Larkin, Church, and Marriott, 
2011); the gendered dimensions of HIV and health-seeking behaviours (also in combination with 
other social categories) (e.g. Doyal, 2009); and the biopolitical aspects of HIV care and the ‘making’ 
of HIV patient citizenship. This latter domain is our primary concern here, and draws heavily upon 
the linked theoretical frameworks of biological and therapeutic citizenship (Nguyen, 2005; Rose and 
Novas, 2005). 
Conscious of the parallel developments in HIV care literatures in public health and social science – 
which characterise HIV and its treatment as a biomedical product of the care cascade on the one 
hand, and critique how this politically constructs a certain patient citizenship and HIV identity on the 
other – we aim to track the use and development of notions of ‘biological’ and ‘therapeutic’ 
citizenship applied to the field of HIV treatment. In doing so, we will assess the relevance of these 
theoretical contributions to understanding current paradigms in HIV care, including in relation to the 
concept of the care cascade in the era of ‘treatment-as-prevention’ (Gardner, McLees, Steiner, Del 
Rio and Burman, 2011). By reflecting on the primarily epidemiological notion of the HIV care cascade 
through a synthesis of published social science studies investigating how the HIV care process shapes 
the making of patient-citizens, we hope to bridge these bodies of knowledge. In so doing, we aim to 
emphasise the particular contribution that critical, and in-depth qualitative, social research makes to 
the understanding of dynamics of HIV care engagement. 
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HIV treatment engagement and the ‘care cascade’ 
An undetectable HIV viral load in the blood significantly reduces the chances of HIV being 
transmitted (Cohen et al., 2011; World Health Organisation [WHO], 2014). In the ‘treatment-as-
prevention’ era, measuring HIV viral load to indicate ART impact is central to definitions of what 
constitutes ‘HIV health’ and also to projecting the trajectory of HIV epidemics (Gardner et al., 2011; 
Hull, Wu and Montaner, 2012; May et al., 2014). ‘HIV care’ itself is thus increasingly envisaged as this 
progressive continuum (De Cock, 2014; Mugavero et al., 2013; Nachega et al., 2014). 
In the continuum, quantitative indicators monitor the number of people who are: living with HIV; 
HIV tested; linked into care post-diagnosis; started on ART; on treatment; and with an undetectable 
viral load (MacCarthy et al., 2013; Kozak et al., 2013). Patient engagement is key to the seamless 
progression through the cascade, from deciding to test, following up appointments, agreeing to start 
and adhering to ART until the virus is suppressed and undetectable in the blood. Patient engagement 
needs therefore to be ‘managed’ to minimise disruption to the care cascade, untreated infections 
and onward transmissions (Nachega et al., 2014). Progression to a state of ‘treated HIV’ pivots on 
the capacity of services to attract and retain patients, and on patients’ commitment to ‘actively’ 
access these in return.  
However, there are three immediately visible limitations to the cascade concept. First, the narrow 
focus on viral load progression (from detectable to undetectable) detracts attention from the 
broader aspects of HIV as a health and social condition, and not only a virus. ‘Treated HIV’ 
represented as a product of the care cascade is blind to the complex of individual and social 
practices, which situate HIV and its care relative to wider definitions of ‘health’. Second, viral 
suppression is not a ‘goal’ that needs to be reached, but rather a ‘state’ that must be maintained 
over time via ongoing systemic care provision coupled with continuous patient re-engagement. 
System- and patient- components and relations are clearly susceptible to multiple changes. Third, by 
delineating the accomplishment of viral suppression as and for public health control, the cascade 
distinguishes success and failure, of services and patients alike, in stark biomedical terms.  
Against an increasing shift towards ART envisaged as ‘prevention’, the concept of the care cascade 
may thus serve to accentuate further what some have termed the ‘re-medicalisation’ of HIV (de Wit, 
Aggleton, Myers and Crew, 2011; Nguyen, Bajos, Dubois-Arber, O’Malley and Pirkle, 2011). ‘HIV 
health’ is increasingly reduced to clinical markers of ART effect, whilst patient engagement in HIV 
care is reduced to specific measures of ART adherence. The discourse and practices of the care 
cascade thus underpin a very particular biomedical constitution of HIV patient-citizens. 
Antiretroviral therapy and patient citizenship 
The history of the HIV/AIDS pandemic is inextricably linked to global activism from people living with 
HIV/AIDS and the deployment of large funding for a global humanitarian response through a 
complex apparatus of transnational and non-governmental organisations (Nguyen, 2009). Political 
and humanitarian movements have been built around the biological condition of HIV infection, and 
are implicated in radical transformations of the relationship between people living with HIV and the 
state. Key here, are developments in HIV medicine and antiretroviral treatments. Although 
historically accompanied by struggles for broader health, economic, social and legal rights, demands 
 5 
for treatment development and access have increasingly taken centre-stage in what has been 
termed a ‘political economy of pharmaceuticals’ (Biehl, 2007, p. 10). 
The unique and mutual constitution of transnational, biomedical and biopolitical claims based on an 
individual yet shared biological condition has meant that AIDS activism first, and HIV/AIDS 
humanitarian interventions later, have been positioned as new forms of citizenship, biological and 
therapeutic respectively (Nguyen, 2005; Rose and Novas, 2005). From the mid-2000s onwards, 
notions of citizenship have informed analyses of HIV and treatment engagement, as well as of other 
health conditions (Petersen, Davis, Fraser and Lindsay, 2010; Rhodes, Harris and Martin, 2013). 
Drawing from Petryna’s (2002) original research tracing how biology and illness were implicated in 
citizenship claims to compensation made by Chernobyl inhabitants, Rose and Novas (2005) propose 
‘biological citizenship’ as the historical citizenship project of the contemporary era that “links 
conceptions of citizens to beliefs about the biological existence of human beings” (p. 440). In the 
biological citizenship project, the citizen holds specific individual rights and responsibilities towards 
his or her own health, and the health of society and future generations too. As a form of governing, 
biological citizenship is at once prescribed top-down from the state (and biomedicine) to citizens 
(and patients) and co-and-re- produced horizontally and relationally amongst citizens themselves, as 
they share a common biological trait or condition. Biological citizens are thus simultaneously 
governed subjects and active and engaged, including in forms of alliance with or resistance to 
biomedicine, science and state regulations as they pertain their health condition. 
Expanding on the concept of biological citizenship to encompass the global health and humanitarian 
response to HIV/AIDS, Nguyen proposes the concept of ‘therapeutic citizenship’ as a series of 
“claims made on global social order on the basis of a therapeutic predicament” (2005, p. 126).  
Based on ethnographic work spanning the early days of the AIDS epidemic and the introduction of 
ARV programmes in West Africa, Nguyen argues that a global AIDS industry increasingly entangled 
with the development industry and with humanitarian intervention has effectively created new 
subjectivities and “life forms: AIDS activism, resistant viruses, and therapeutic citizens” (Nguyen, 
2005, p. 126). The therapeutic citizenship project he describes in West Africa is supported by a 
‘vanguard’ of local activists (Nguyen, 2005), fashioned through ‘confessional technologies’ in peer-
support groups (Nguyen, 2010, pp. 35-50) modelled on early (US) gay activism, evangelical 
movements (Nguyen, Ako, Niamba, Sylla and Tiendrébéogo, 2007) and counselling techniques 
(Nguyen, 2013). 
Through these and other ‘technologies of the self’ (Foucault, 1988) people living with HIV and AIDS 
in resource-scarce (and treatment-scarce) settings learn to tell a certain story, and those who 
succeed in performing their role are ‘triaged’ into ART as potentially more valuable members of an 
emerging HIV/AIDS community (Nguyen, 2010, pp. 80-110). Thus, ties originally intended to forge 
solidarity and support amongst positive members are changed by the (partial) arrival and (scarce) 
distribution of life-saving antiretroviral medicines through patchy services, interventions and small 
personal networks. 
 
APPROACH 
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Conscious of the growing body of literature investigating the social dynamics of HIV treatment 
engagement, we explore the use of frameworks of therapeutic and biological citizenship in 
qualitative social science studies of HIV, HIV care and patient citizenship. In doing so, we are 
particularly interested in considering how such work can contribute to situating HIV treatment 
engagement in relation to epidemiological notions of the HIV cascade of care. The context-specificity 
of in-depth social research does not reduce its capacity to illuminate general global health 
frameworks and to document their emergence and effect. A collective synthesis of critical case 
studies can provide a nuanced yet integrated understanding of the making and implications of 
particular ways of looking at and intervening in major health issues, such as the HIV pandemic.  
Given that social science literature specifically focused on the cascade of care is nascent, we began 
by using ‘adherence’ as an initial proxy to inform our search of qualitative research on HIV care 
engagement. This yielded 222 article abstracts and 37 article reviews of qualitative studies published 
since 2005. Among these were studies which had a specific interpretive emphasis that tended to use 
in-depth methods (multiple qualitative methods or ethnography) to explore experiences of people 
living with HIV, including those related to different stages of the cascade of care, and that drew upon 
social theories, including those related to citizenship. A total of 82 article abstracts fell into this 
category, and these were the ‘pool’ for our initial review. Two seminal essays by Paul Rabinow 
(1992a, 1992b) were added early on as they provided the foundations of the concept of 
‘biosociality’, which we were aware, from previous readings, would be at the core of biological and 
therapeutic citizenship theories. 
Our review proceeded in two steps. First, we considered each of the 84 article abstracts for their 
relevance to three questions: 1) Does the article make explicit reference to concepts of biopolitics, 
biosociality, biological, therapeutic or health citizenship?; 2) Does the article focus on HIV treatment, 
adherence, care or care engagement?; and 3) Does the article use qualitative methodology 
empirically or offer a theoretical framework that can be used to inform such qualitative research? 
This led to us honing our selected articles for review to 22. Through an iterative process involving 
citation tracking in article bibliographies, additional searches of individual social science journals and 
of relevant social science books or monographs, we identified a further nine articles and book 
chapters meeting our criteria, for a total of 31 overall. 
Second, we undertook an additional electronic search, using Medline, of journal articles published 
since 2005 and focused specifically on HIV and citizenship using the key words of: biological 
citizenship and HIV; therapeutic citizenship and HIV; health citizenship and HIV. After checking for 
duplicates, six were selected. Thus, a total of 37 articles and chapters (hereafter ‘papers’) were 
included. 
Of the 37 papers in our review, nine were summarised, using a narrative approach, for their 
theoretical contribution to definitions of biological and therapeutic citizenship (Table 1). The 
remaining 28 (Table 2), largely empirical case studies, were synthesised using a structured approach 
to extract and distinguish content alongside original author interpretations. Having extracted key 
content and author interpretations of these 28 papers, we worked across them to produce a third 
level of abstraction focusing specifically on our key areas of analytical interest (engagement; 
adherence; patienthood; citizenship). Our summaries of content were thus coded, and re-coded, 
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through a process of iteration, enabling the identification of key themes, which formed the basis for 
our synthesis. 
In our synthesis, empirical findings, and the ways authors presented them, were coded in place of 
original excerpts of data, as many of the reviewed papers tended not to emphasise low inference 
description and accordingly reported little direct quotation but instead emphasised theory-informed 
interpretation. Boxes 1-3 present some illustrative extracts and field observations from the reviewed 
literature across the core themes, which shape our synthesis.  
In addition to these core papers forming the basis of our synthesis, we also draw upon wider 
published literature, especially where it has informed the studies reviewed in the synthesis, in order 
to illuminate the analyses we present. Where such additional references appear in the results 
section, they have been marked with cf. for readers’ clarity. 
Emerging themes 
We identified three primary thematic areas of study that form the basis of our synthesis: patient 
engagement (how people living with HIV engage with HIV-related knowledge and treatment 
intervention); therapies and politics (how HIV treatment engagements are contextualised politically, 
including in relation to the state); and biosociality and responsibility (how engagements with HIV and 
social identities and relations are mutually constituted). 
 
PATIENT ENGAGEMENT 
Patient engagement in HIV care is situated in relation to its specific social context, which shapes the 
multiple and competing meanings of HIV intervention to would-be patients, including how 
biomedical treatment opportunities are negotiated in everyday social life. In addition, there is an 
emphasis on exploring notions of engagement through the ways in which people living with HIV 
interplay with biomedical expertise, and how this shapes HIV and health identity. 
‘Deflecting’ biomedical knowledge and practice 
Side-effects linked to ART emerge as central elements of meanings of ‘HIV health’ and ART held by 
patients (Alcano, 2009; Cataldo, 2008; O’Daniel, 2014; Persson and Newman, 2006). Clinicians may 
tend to think of the immune system as the locum of the patient’s health (Persson and Newman, 
2006), and of ARVs as restoring and protecting the patients’ strength, but side-effects of ARVs can 
compromise strength as experienced by the patient (Alcano, 2009; Cataldo, 2008; Box 1, extr.1). 
What clinicians might conceive of as ‘tolerable’ side-effects, and what patients might find difficult to 
manage day-to-day, may differ (Persson and Newman, 2006). 
Ethnographic studies report that participants may find that ART side-effects render physically 
demanding jobs difficult (Alcano, 2009; Cataldo, 2008). Amongst residents of favelas in Rio de 
Janeiro precariously employed in manual labour ART is seen as a “luxury” because of the toll of side-
effects (Cataldo, 2008, p. 905), whilst positive male construction workers in Milan comment that 
they cannot afford weakness or tiredness (Alcano, 2009) interfering with their work (Box 1, extr. 1- 
2). 
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Globally, treatment side-effects, dietary requirements, the need to rest and to take treatments at 
set times of the day all create obstacles to working activities, especially for those employed in low-
paid jobs requiring long hours of hard physical work, often at irregular times and with little flexibility 
(Doyal, 2013). ART can thus become financially non-viable, not only because of its cost but also 
because of its demands, and adherence is adjusted accordingly. ART is adapted to competing 
requirements made upon the body, with people balancing the preservation of a ‘biomedical’ 
(Persson and Newman, 2006) or ‘pharmaceutical’ (Biehl, 2007; Mattes, 2012) self against a ‘side-
effects free’ self that is able to work (Alcano, 2009; Cataldo, 2008). 
Studies thus point to a ‘situated rationality’ whereby the perceived health risks of ‘non-compliance’ 
to biomedical advice may be juggled alongside securing the welfare of self, children or other 
dependants, including protecting damage to reputation and social position through work (Alcano, 
2009; Cataldo, 2008; Mattes, 2011). In the harsh contexts of daily survival, such as that described by 
Mattes in Tanzania (2011), ART adherence may become a measure of last resort to stay alive, rather 
than a form of proactive and ongoing self-care. Here then, people can be seen to ‘manipulate’ 
(Niehaus, 2014) or ‘deflect’ (Alcano, 2009), rather than outright resist, biomedical knowledge and 
practice. Treatment engagement becomes a matter of accommodation, with the take-up of 
clinicians’ guidance moderated according to situation (Box 1, extr.3). 
In addition, O’Daniel’s (2014) ethnography among poor African-American women in Midway (North 
Carolina, USA) shows that even in absence of side-effects, immediate problems of homelessness, 
destitution, and social isolation reduce space for attending to HIV health, and increase fear of stigma 
and of the loss of already scarce support networks. While interacting with HIV services and (mostly) 
adhering to HIV treatment, O’Daniel (2014) found that the most destitute amongst these women 
displayed little overt understanding of, or interest in, the progression of their HIV or their clinical 
outcomes (Box 1, extr. 4). 
This might be described as a form of ‘utilitarian’ care engagement (cf. Rhodes et al., 2013). Practices 
of deflection, adaptation, and relative indifference, run counter to the clinical requirements of 
patient engagement characterised by exemplary adherence through the ‘cascade of care’. 
Nonetheless, the very practices which deflect biomedical treatment expectations still serve to 
accommodate them, and many such participants collect, store and take their medicines whenever 
and as much as possible (Cataldo, 2008). Deflected biomedicine is not a challenge to it, and often 
preserves its idealisation, even in social conditions that mitigate against its immediate realisation. 
Indeed, deflection can be simultaneously reasoned as necessity and as personal failure as patients 
navigate their way through competing social, material, moral and therapeutic demands. 
In contrast to the ‘single rationality’ of ‘treated HIV’ as synonymous with viral suppression brought 
about by patients’ strict adherence and responsibility towards health (Beckmann, 2013; Niehaus, 
2014; Thomas, Aggleton and Anderson, 2010), a ‘situated rationality’ of ‘HIV health’ envisages 
biomedical engagements as relational. To address what Mattes (in Tanzania) refers to as the 
“rationale of being problematic” (2011, p.170), patients’ perspectives on ART may be appreciated as 
non-dichotomous, multiple and context-dependent (Box 1, extr. 5). Niehaus (in South Africa) 
likewise reminds us that “knowledge about sickness does not imply unswerving commitment to one 
set of beliefs” and “practical considerations often outweigh explanatory consistencies” (Niehaus, 
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2014, p. 362). Compliance to biomedicine, Niehaus argues, is one way people may comply with one 
form of ‘authority’, alongside that of priests, healers, and older family members. 
Adherence is thus a form of ‘submission’ susceptible to change, and which can be modified in 
relation to other forms of authority. Equally, seemingly ‘irrational’ behaviours, such as interrupting 
treatment (Beckmann, 2013; Persson and Newman, 2006), sharing antiretrovirals with others 
(Cataldo, 2008), changing doses, or using alternative medicines and healing practices (explicitly or 
implicitly) against clinicians’ advice (Niehaus, 2014; Thomas, Aggleton and Anderson, 2010), are ways 
in which people enact agency in the context of their day-to-day needs. 
Qualitative longitudinal research in Serbia, for instance, illustrates how patient narratives of 
‘disengagement’ from treatment, and even of apparent ‘treatment resistance’, are ways in which 
people act to cope with and respond to treatment access insecurity or pervasive uncertainty 
(Bernays and Rhodes, 2009). At the same time, narratives of disengagement entertain the hope of a 
better treatment future, thus acting to deflect or defer rather than fundamentally resist engagement 
with biomedical practices. 
Treatment literacy and expertise 
Uncertainty is also a feature of biomedical scientific knowledge itself that is made evident to people 
living with HIV in the context of side-effects, unexpected reactions to treatment, treatment changes, 
and the ‘failure’ of therapy to restore a sense of health that is compatible with the lives people try to 
live (Alcano, 2009; Davis, Frankis and Flowers, 2006; Flowers, 2010; Mazanderani and Paparini, 2015; 
Persson and Newman, 2006; Thomas, Aggleton and Anderson, 2010). Treatment engagement is thus 
not only an accommodation to the particularities and uncertainties of social situation but also of the 
‘treatments’ themselves, and their multiple effects. As the above case example of Serbia illustrates 
(Bernays and Rhodes, 2009; cf. Rhodes, Bernays, and Terzić, 2009), ‘patient adherence’ to treatment 
is at least in part a structural effect of ‘state adherence’ to delivering secure and uninterrupted 
treatment, with engagements with biomedical expertise moderated in relation to a circulating 
culture of information scarcity. 
Rose and Novas (2005) suggest that different technologies and practices actualise citizenship, 
including what they term informational biological citizenship, which refers to engagement with 
“specialized scientific and medical knowledge of one’s condition” (p. 442). This form of citizenship 
closely echoes the emphasis on treatment literacy and expertise characterising the rise of ‘expert’ 
(cf. Kielman and Cataldo, 2010) and ‘active’ (cf. Barbot, 2006) patienthood in contemporary public 
health. Here, gathering, sharing and debating biomedical information on HIV is both a process of 
‘empowerment’ of the patient vis-a-vis the authority of clinicians, and of ‘responsibilisation’ of the 
patient-citizen in the context of their condition. 
Emphasis on treatment expertise has ramifications for patient-clinician discussions and for how 
treatment literacy may be imparted. For example, concerns about appearing ‘foolish’ or causing 
‘offense’ to the doctor may manifest in patients’ reticence to disclose their use of alternative 
medicines, as is reported to be the case with African men and women living with HIV and accessing 
UK national health services (Thomas, Aggleton and Anderson, 2010). Rather than experts on equal 
grounds with their care providers, patients may be informed just enough to know what not to say 
(Box 1, extr. 6). 
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Others too have observed how adherence discourse, as circulated in ART literacy sessions or other 
clinical encounters, can be disempowering. Here, competing forms of local knowledge can be 
discouraged, and everyday demands that affect treatment-taking discounted, often through the 
threat of treatment failure, and consequent sickness or death as a result of poor patient adherence 
(Beckmann, 2013; Mfecane, 2011). 
The case of ‘blood counts’ 
Particular attention has been paid to the meanings assigned to blood tests or ‘counts’, and their role 
in monitoring CD4 counts and viral load and the progression of HIV infection. The ethnographic work 
of Meinert, Mogensen and Twebaze (2009) in Uganda, for instance, focuses on CD4 counts as the 
“technological hook that clients can hang their hopes on” (p. 203), whilst the qualitative research of 
Flowers (2010) in the UK suggests that ‘health’ among people living with HIV is increasingly being 
measured by blood counts alone, turning the body into a “mere setting for action” (p. 110). Most 
such studies frame blood counts as technologies of discipline (Alcano, 2009; Meinert et al., 2009; 
O’Daniel, 2014; cf. Foucault, 1978): while indicators of what the virus is doing, changes in HIV viral 
load can also reveal to the clinician what the patient might be doing. Holding the potential for 
unwanted disclosure and revelations about adherence, blood counts are clinical evidence indicating 
whether patients-clients are maintaining their part of a therapeutic deal (Meinert et al., 2009), 
acting as a kind of truth-telling device (O’Daniel, 2014; Box 1, extr.7). 
Among people living with HIV interacting with public or welfare services, blood counts may be 
further seen as “gatekeepers” (Meinert et al., 2009, p. 206), or stand for “biolegitimacy” (Marsland, 
2012, p.472; cf. Fassin, 2001), enabling access to additional forms of support, such as state benefits, 
housing, food staples and other goods. This system can work in opposing ways, however. In some 
settings, only those with very low CD4 counts (indicating advanced disease progression) may be 
eligible for welfare support, a potential disincentive to ART adherence in the context of otherwise 
scarce resources (cf. Leclerc-Madlala, 2006, in South Africa). Elsewhere, only those with a ‘good’ CD4 
count can prove that they are engaged with health services and stable ‘enough’ to access additional 
resources such as housing support (O’Daniel, 2014, in the US).  
In all cases, the meanings assigned to biomarkers – as vehicles or obstacles to other forms of support 
– exemplify how biomedicine is often able to shape specific subjectivities insofar as its promise 
stretches beyond clinical care itself (O’Daniel, 2014). In the absence of further incentives to ‘achieve 
viral suppression’, patient engagement, especially in the context of poverty, can alternatively be 
mitigated by practices of deflection or indifference towards HIV health and treatment. 
Not only disciplinary tools, biomarkers also shape interpretations of life and self with HIV 
(Mazanderani and Paparini, 2015). Blood counts can be seen as forms of ‘abstract knowledge’ about 
HIV, functioning as ‘maps’: where they rise as a result of ART, they “give a sense of direction, and 
ability to have plans and make priorities”, turning however into “uncertainties and disorientation” 
when they do not rise as fast as expected (Meinert, et al, 2009, p. 204). Yet, such maps of an ‘inside’ 
are always framed by an ‘outside’: the interpretation of bio-information is situated in everyday social 
relations, indicating life situation and social condition. 
In this way, blood counts chart socio-economic trajectories in relation to food, work and immunity 
(Marsland, 2012). Food, for instance, is recommended for ARVs to work effectively and, in turn, 
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ARVs are perceived to cause hunger (cf. Hardon et al., 2007; cf. Kalichman et al, 2015; cf. Kalofonos, 
2010). In the context of often otherwise rationed resources, CD4 counts do not drop when patients 
fail in their adherence, but when they are unable to purchase sufficient food to sustain adherence. 
Medical records thus tell stories of the alternate fortunes and misfortunes of those living with HIV, 
especially in precarious circumstances, just as they tell a story of the clinical and pharmaceutical care 
available to them at different times. In so doing, bio-information provides personal as well as 
political substantiation of the changing fate of people and their nations alike. 
 
THERAPIES AND POLITICS 
The ways in which ART is provided to, fought for, and accessed by people living with HIV constitute 
new forms of therapeutic citizenship (Nguyen, 2010). These intersect with extant relationships 
between self and state prior to HIV and ARVs, whilst at the same time “the way a state deals with 
AIDS reveals its statecraft” (Biehl, 2007, p. 11). 
ART as a link between body and state(s) 
The ethnographies of Cataldo (2008) and Biehl (2007) document an emphasis on social justice and 
the redistribution of resources through which grassroots organisations effectively articulated their 
demands for ARVs in the early days of the Brazilian epidemic. Similarly, earlier claims to the right to 
ART in South Africa were characterised by dramatic competition with a strong nationalist discourse 
about ‘authentic’ African citizenship, infamously expressed through President Mbeki’s AIDS 
denialism (Kagee, Swartz and Swartz, 2014; Robins, 2005). According to Kagee et al. (2014), the 
struggle for ARVs in South Africa signalled both the rise of an international therapeutic citizenship 
and an engagement with emerging national identity issues post-apartheid (see also Robins, 2005). 
Yet studies reviewed here note that the quality of HIV care often surpasses other domains of state 
health and social care, particularly in lower income settings where ART provision is funded by an 
uneven mixture of agencies, a phenomenon described by Whyte, Whyte, Meinert and Twebaze, 
(2013) in Uganda as the “projectified” landscape of HIV care (p. 143). ART can frequently be 
distributed amidst a lack of other services, exposing a ‘state’ that is “pharmaceutically present but 
institutionally absent” (Biehl, 2007, p. 285). This paradox has multiple divergent ramifications for 
patient-citizens: further collective engagement and demands on the one hand, but also a divisive 
pressure in the competition for resources on the other, or else a kind of apathy as the 
“pharmaceutical wellbeing” (Biehl, 2007, p. 302) afforded by ART is not enough to give rise to a 
socio-political sense of possibility. 
For example, in the favelas of Brazil’s Rio de Janeiro (Cataldo, 2008) and in Kenya’s national hospitals 
(Moyer, 2014), patients may respond to the variation in the quality of the health services provided 
by developing a stronger sense of entitlement to better care beyond HIV. In this sense, therapeutic 
citizenship is enacted when people become more “sensitive to their individual rights” (Cataldo, 
2008, p. 907; see also Biehl, 2007) through ART provision and then seek to extend these to other 
areas of governmental services. Here, state provision of ARVs represents a link between individual 
‘politicised bodies’ and the state, opening up the possibility of further interaction and involvement. 
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Free ART provision on the part of the state represents the inclusion of people otherwise socially and 
economically marginalised, for example those living in the South African townships (Robins, 2005), 
the patients of a non-governmental house of support in Brazil’s Salvador de Bahia (Biehl, 2007), or 
the residents in Rio de Janeiro’s favelas who feel “privileged” because their government is both 
manufacturing and providing their HIV medications (Cataldo, 2008, p. 906).  
As people depend on governmental HIV programmes, however, their individual fate becomes 
inextricable from their national economy. A state of anxiety among people with no alternative 
means to HIV care can ensue (Box 2, extr.8). In the example of Serbia and Montenegro (Bernays and 
Rhodes, 2009), insecure availability of ART means patients worry daily about interruptions to their 
life-saving medications and the rumours circulating about ART rationing. Disengagement from the 
state and services, rather than the uptake of political action or engagement, manifests the anxiety 
produced by such uncertainty. Taking ART ‘on’ and ‘off’ is deemed more dangerous, and more 
difficult to cope with, than making a decision to avoid treatment altogether (Bernays and Rhodes, 
2009; Box 2, extr.9). 
ART and communities in the biomedicalisation of HIV 
The gathering of activist communities around a shared biological condition is a core feature of 
biological and therapeutic citizenship (Nguyen, 2005; Rose and Novas, 2005). Whilst the seminal 
ethnographies of Nguyen in West Africa (2010) and Biehl in Brazil (2007) documented the early days 
of treatment activism following the development and distribution of ARVs, recent studies framed by 
these concepts concentrate on the increasingly ‘individualising’ features of biological citizenship 
under the influence of biomedical understandings of HIV as a ‘manageable’ and ‘normalised’ chronic 
condition following the scale-up of ART (cf. Moyer and Hardon, 2014). 
Studies we reviewed suggest that the accent placed on individual responsibility in the management 
of HIV is a prominent and consistent feature of current ART provision worldwide. Even where 
treatment activism was originally linked with rights-based discourses beyond healthcare (as in the 
case of South Africa), many observe a progressive reduction of the ‘social problem’ of HIV to an 
individualised concern (Biehl, 2007; Kagee et al., 2014; Mfecane, 2011; Robins, 2005). In high-income 
settings with free healthcare, such as the UK, neoliberal versions of HIV care are increasingly turned 
into a “depoliticised form of health consumerism” (Robins, 2005, p. 12). 
Grassroots NGOs become larger institutions in partnership with the state, and are increasingly 
oriented towards providing healthcare services rather than mobilising political activism (Robins, 
2005; Mfecane, 2011; cf. Seckinelgin, 2008). Bureaucratisation and the need to attract funding 
through complex donor schemes set up hierarchies and weaken ties within communities (Biehl, 
2007; Robins, 2005). Yet community organisations continue to be tasked with supporting those who 
‘fall out’ of the patient/provider contract premised on the individualised ‘management’ of HIV via 
ART. When such ‘failed’ patients cannot be accommodated by NGOs, they fall out of the picture 
altogether (Biehl, 2007; Kistner, 2009; Nguyen, 2010; Mazanderani and Paparini, 2015; Squire, 
2010). 
As the “master status” (Flowers, 2010) of HIV identity is diluted through a (chiefly biomedical) 
emphasis on the normalisation of HIV as ‘just another’ chronic condition, some reason that the very 
bases for HIV biological citizenship comes undone (Robins, 2005) and a fragile sense of HIV 
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community (Biehl, 2007) creates hurdles for NGOs’ response. Without HIV community, it becomes 
challenging to engage with ‘HIV identity’, considered central to a collective and relational drive 
towards ‘responsibility’ and adherence (Robins, 2005). The dissolution of ties of solidarity in the face 
of the putative normalisation of HIV thus makes it easier for some to be ‘left behind’, in varying 
degrees of social and moral isolation (Squire, 2010). 
In settings where ART access is uneven or insecure, HIV care may become an outcome of 
competition between individuals in need rather than of collective actions (Bernays and Rhodes, 
2009). Different examples of ‘triage’ into therapy (Nguyen, 2005) can be found in these studies: ART 
provided only to patients attending compulsory adherence-focused ‘support’ groups in South Africa 
(Mfecane, 2011); ART provided only to those people who inject drugs in Russia who can 
demonstrate sufficient efforts to stop using drugs (Rhodes and Sarang, 2012); or amongst Ugandan 
patients assessed for their potential compliance through educational sessions and pill counts at the 
time of refill (Whyte et al., 2013). When state offers of treatments are made contingent upon 
patients performing sufficient deservedness, a narrative of disempowered may be produced, far 
from the ideal of the ‘engaged’ and ‘active’ community of (biological) interest envisaged in 
citizenship claims (Mfecane, 2011; cf. Rhodes et al., 2013). 
 
BIOSOCIALITY AND RESPONSIBILITY 
As mentioned early on, biological and therapeutic citizenship theories – and the studies they frame - 
are commonly connected to Paul Rabinow’s conceptualisation of a nascent ‘biosociality’ (1992a, 
1992b) pertaining new forms of interaction and “belonging” (Nguyen, 2010, p. 178) based on shared 
biological characteristics. Biosociality refers to a process whereby people gather via the shared 
learning and experience of specific health conditions related to newly-identified objects in the body, 
such as genes or viruses, otherwise devoid of socio-cultural contextualisation. Specific techno-
scientific interventions pinpoint common biological traits, as in the case of drug treatments, drug 
regimens or clinical tests. HIV treatment, and not only HIV status, is thus productive of a new 
biosociality, as the practice of biomedicine and pharmaceutical technologies invite people to 
associate outside their everyday social relations and networks. 
Going back to ‘normal’? Returning to sociality from a new biology 
In his account of treatment activism in South Africa, Robins (2005) refers to a “new family” created 
through nascent biosocial communities linked to the experience of HIV positivity (p. 10), whilst Biehl 
(2007) describes the residents of a grassroots AIDS hospital in Salvador as a “biocommunity” (p. 
324). Both authors note that biosociality emerges in the context of the stigmatisation of HIV, parallel 
to an observation made by Rose and Novas (2005) regarding biological citizenship as a project of 
inclusion in response to discrimination (pp. 448-451). Gay activism in the context of the early AIDS 
epidemics in the US and Europe is most often cited as an example of mobilisation against fear, 
negative propaganda, and political and therapeutic neglect (cf. Epstein, 1996; Rose and Novas, 
2005).  
Echoes can also be found in other literatures which frame HIV diagnosis as a ‘turning point’ through 
which people from marginalised groups find new meaning, direction and belonging. Although these 
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studies do not necessarily refer to Rabinow’s idea of biosociality, and are articulated as individual 
journeys of identity reconstruction around a stigmatised condition, they nonetheless point to forms 
of sociality emerging from a new biological condition of HIV seropositivity, which help to frame new 
understandings of self and community (cf. Berger, 2010; cf. Watkins Hays, Pittman-Gay and Beaman, 
2012). 
Yet many studies reviewed here unpack and contest the idea that a new sociality can be forged via 
HIV and ART. HIV stigma is not seen as a cohesive force for the stigmatised but as an ostracism 
leading to self-silencing. New forms of HIV-related sociality are thus described as a product of the re-
shaping of existing social ties rather than of biological connections. 
For instance, Marsland (2012) argues that HIV and ARVs in Tanzania are insufficient to produce a 
new biosociality and that it is the shared experience of clinic and treatment practices that enables 
people with pre-existing links to gather under the recognised predicaments of HIV and ART. 
Similarly, Whyte et al. (2013) observe that social connections which pre-date HIV diagnosis provide 
an “already-existing personalised web of influence” that people living with HIV in Uganda perceive as 
more salient than HIV bio-status alone as networks that can “be set in motion to get things done” (p. 
149). In both cases, study participants lived in households affected by HIV wherein family relations 
were among the primary ‘ties’ in relation to life with HIV. They were also weaved into healthcare via 
personal acquaintances, not as ‘individual’ HIV patients, which suggests resourcefulness but also an 
inherent “fragility” as different people have unequal access to influential ‘actors’ (Whyte et al., 2013, 
p. 147). In the creation of HIV-related sociality, pre-established social relationships may take 
precedence over new forms of ‘bio’-social solidarity or connection. 
Beckmann (2013) further explores how people in Tanzania wish to “return to a normal life” more 
than they wish to create new (bio)social networks (p. 166). Once health is ‘restored’ through ART, 
the main preoccupation is not to assume a new HIV identity or enter a new biosocial ‘family’, but 
rather to disclose one’s status to as few people as possible, both to avoid stigmatisation and to 
attempt to seamlessly re-commence life post-HIV diagnosis  (Box 3, extr.10). The quest for solidarity 
is thus overridden by the social risks involved in disclosure and, if ART produces any physical or 
visible side-effects, even treatment itself comes to be seen as threat to a return to normality. 
People living with HIV in Tanzania express the desire first and foremost to develop ways to sustain a 
‘life worth living’, embedded in social relations and exchange (Marsland, 2012). Other studies add 
weight to this observation: Levy and Storeng note the need for income among HIV positive women 
in South Africa before they can engage in any discourse of ‘positive living’ (2007); men engaged in 
peer-support in Cape Town want to work, earn money and resist the category of the “HIV vulnerable 
sufferer” (Colvin, Robins and Leavens, 2010, p. 1187); and Mattes finds that “dignity and social 
recognition” may constitute a core aspiration for some of his participants much more than the 
creation of a “pharmaceutical self” (2012, p. 81). 
As engagement with biomedicine is ‘deflected’, HIV biosociality is edged to the periphery, only 
momentarily incorporated into primary forms of sociality. New forms of HIV sociality, although 
borne out of existing social ties rather than biology, nonetheless begin to modify existing social 
structures from the perspective of biology. Biosociality thus progressively intersects with, and might 
only eventually supersede, previous sociality over the long course, rather than in any immediate or 
automatic fashion (Rabinow, 1992a, 1992b).  
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Adherence and responsibility: towards whom? 
An emphasis on personal responsibility frames the moral expectations placed on the therapeutic 
citizen’s health behaviours (Rose and Novas, 2005; Petersen et al., 2010). Social discourses of 
responsibility have also emerged from public health framings of the management of HIV risk, as 
moral counteraction to the negative sanctioning of people with HIV as ‘deviant’. Biomedical 
responsibility especially is performed through adherence to ART, protecting the self through 
protecting immunity (Persson and Newman, 2006), reducing the risks of other illnesses, and 
minimising onward HIV transmission (cf. Persson, 2013).  
Testing, or ‘knowing one’s status’, begins the process for “responsible citizens who have taken 
action” (Russell, Namukwaya, Zalwango and Seeley, 2015, p. 5). Additional demonstrations of 
‘health-promoting’ and responsible behaviours include abstaining from sex or using condoms, 
disclosing serostatus to partners, following guidance on ‘positive living’, advocating for those with 
the same condition, keeping informed, ‘active’ and engaged with healthcare and surrounding issues 
(Flowers, 2010; Levy and Storeng, 2007; Mazanderani and Paparini, 2015; Nguyen, 2010; Rose and 
Novas, 2005; Russell et al., 2015). Health workers are indeed often ‘framing agents’ instrumental in 
drawing the parameters of responsible citizenship (Russell et al., 2015).  
Studies reviewed observe that responsibility is less an individual self-preserving endeavour than a 
“socio-moral phenomenon” (Mattes, 2012, p. 77) imbued with obligations towards the “hidden 
collective” of family, kin and community (Marsland, 2012, p. 474). Adherence to treatment 
expresses responsibility as reciprocity towards the “consistent good will of potential helpers... 
required for survival” (Ware et al., 2009, p. 45) and preserves physical health necessary to perform 
income-generating and caring activities for the collective (Colvin et al., 2010). Studies in South Africa 
cast adherence as a “pro-social behaviour furthering the common good” (Kagee et al., 2014, p. 107), 
with doing one’s best to stay healthy and to ‘self-improve’ via ART (Colvin et al., 2010) enacting 
responsibility towards communities. Likewise in Uganda, a collective therapeutic citizenship is 
“socially fashioned” by people living with HIV, based on responsible condition management and 
allegiances to healthcare workers and other patients alike (Russell et al., 2015, p. 8).  
Powerful associations between the need to be healthy and to care for others constitute a collective 
moral economy of adherence which, for Ware et al. (2009), explains how people in sub-Saharan 
Africa manage to adhere as well as – or better than – those in higher income settings, in spite of the 
multitude of barriers they face (cf. Hardon et al., 2007). Yet Beckmann (2013) argues that ART 
programmes (in Tanzania) “shift the burden of responsibility for success... onto the shoulders of 
patients” despite the limits to responsible adherence in the context of poverty and survival (p. 161). 
Adherence and the importance of keeping the virus suppressed (now and in future) are threatened 
by the lack of opportunity for social and economic lives in the present. 
Adherence then, is seen as a social (as well as a biomedical) technology requiring collective practice 
and commitment (from patients, healthcare workers, peer mentors, family members) (Biehl, 2007; 
Moyer, 2014), and responsibilisation may be articulated as constituting a means to provide and care 
for others. Responsibilisation can thus incorporate adherence but it extends further, as its reason-to-
be is the preservation of social ties, above and beyond the preservation of health. 
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DISCUSSION 
We have focused on social science studies that have engaged with ideas of biological and 
therapeutic citizenship in their accounts of HIV and its treatment. The literature reviewed is highly 
context-specific and grounded primarily in the global south (and Africa in particular), whilst in 
dialogue with discourses around global health.  An overarching theme concerns the limits to the 
actualisation of citizenship in the context of competing social needs, alternative forms of knowledge 
and expertise, and structural relations, especially patterns of poverty and inequity. 
Empirical case studies note tensions in the language and expectations of patient citizenship, the 
emphasis on individual responsibilisation, expertise, engagement and awareness of rights, in 
contrast with some of the situated experiences of HIV health and healthcare, particularly in lower 
income settings (Beckmann, 2013; Biehl, 2007; Cataldo, 2008; Levy and Storeng; Marsland, 2012; 
Mattes, 2011, 2012; Meinert et al., 2009; Mfecane, 2011; Niehaus, 2014). This has led to a 
questioning of the scope of the theoretical frameworks of biological and therapeutic citizenship 
(Kagee et al., 2014; Kistner, 2009; Meinert et al., 2009; Mfecane, 2011; Whyte et al., 2013), also in 
instances where these are applied to conditions other than HIV (cf. Rhodes et al., 2013). 
The limits of HIV citizenship and the ‘health contract’ 
Whyte et al. (2013) propose that the concept of ‘therapeutic clientship’ might more appropriately 
describe patron/client relations, embedded not only in funder/provider HIV-aid exchanges on a 
global scale, but also in provider/patient encounters in health systems characterised by scarcity, 
rationing, and conditional ART provision. Whilst a neoliberal reading of ‘clientship’ “suggests 
enlightened consumerism and user friendliness” (Whyte et al., 2013, p. 150), in Uganda the 
patronage system of therapeutic clientship casts treatment provision as a profoundly social, and 
often tenuous, form of healthcare where there is little room for negotiating inclusive citizenship 
through treatment. This contrasts with the purported, idealised ‘health contract’ (Robins, 2005; 
Kistner, 2009) between HIV patients and their clinicians, which hints at shared duties and reciprocal 
rights in a supposedly neutral context of equal political grounds. 
Whether offered on condition of compulsory treatment education and attendance at peer group 
discussions (Mattes, 2011; Kistner, 2009), or whether non-coercive by emphasising 
“responsibilisation, consent and self-regulation” (Colvin et al., 2010, p. 1183), therapeutic clientship 
is implicitly unequal. Support group members can at times be treated as little more than “blank 
slates waiting to be filled with health and treatment information” (Mfecane, 2011, p. 133). ‘Reliable’ 
and ‘deviant’ patients are separated to maximise resource allocation through an array of social and 
‘confessional’ technologies (Nguyen, 2010), and the performance of the patient-citizen “comes to 
include the conditions and means for survival” (Kistner, 2009, p. 4). 
Therapeutic clientship reproduces a version of “healthcare as charity” in which “entitlements 
become concessions” (Biehl, 2007, p. 310) to those who display ‘deservedness’ (Rhodes and Sarang, 
2012). Reciprocity is required from the side of the patient-receiver who must give back through 
adherence first and foremost, but also through openness, patience, clinic attendance, gratitude and 
allegiance to the biomedical rationalities of ART (cf. Bernays et al., 2010; Biehl, 2007; Whyte et al., 
2013; Mazanderani and Paparini, 2015). Thus, as Kistner (2009) suggests, the only aspect of 
biological citizenship that is enacted in circumstances where people are entirely dependent on these 
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forms of unequal HIV care, is the way in which patient-citizens are actually governed through 
biomedicine and made responsible not only in relation to their health, but also in relation to the 
state as a whole, “under the threat of the withdrawal of the means of life” (p. 1). Biological citizens 
rally behind a biological condition to seek re-inclusion under the protection (and provision) of the 
state rather than to have their biological rights recognised and needs met. When the state is 
‘absent’, claims are made on global humanitarian grounds (Nguyen, 2010). 
People living with HIV in many settings access healthcare in the context of otherwise disappearing 
public services infrastructures (Biehl, 2007; Whyte et al., 2013). But Kistner (2009) argues that 
protection and improvement of health and social care systems cannot be actualised through 
biological citizenship projects: they require broader political and economic struggles that are often 
beyond the capacities of patient-citizens, precisely because they depend so heavily on state ART 
provision. 
Furthermore, biological inclusion (or re-inclusion via responsibilisation and adherence) runs parallel 
to social exclusion (Kistner, 2009): the same people ‘failed’ by health and social care systems 
become those who cannot keep up their side of the new health contract. Examples of this abound in 
the studies reviewed, describing the conditions of those who are homeless (O’ Daniel, 2014), have 
substance use issues that preclude their access to ART (Rhodes and Sarang, 2012), are ‘troublesome’ 
in instances of communal institutional living (Biehl, 2007), or exist on the margins, in one way or 
another, to the extent that they ‘fall out’ of healthcare relations despite being in utmost need (Biehl, 
2007; Mattes, 2011). 
Perhaps the limits of citizenship frameworks for understanding ART and care engagement are to be 
found in the application of the theories to empirical contexts and examples other than those for 
whom they were originally conceived. For example, Rose’s and Novas’s (2005) concept of biological 
citizenship illuminates clearly the trajectory of early gay activism in relation to the US HIV/AIDS 
epidemic and successfully links this to the mobilisation of other, new, biosocial communities, for 
example around genetic conditions. It may lose some of its analytical power vis-à-vis landscapes 
where health systems and techno-science are barely visible. 
Similarly, therapeutic citizenship might more accurately describe the biopolitical repercussions on 
local lives of the introduction of ARVs at a global scale. It addresses that very momentum in the shift 
in sovereignty beyond national health systems, tracking HIV and AIDS as an extraordinary global 
health experiment ushering in and transposing a whole apparatus across settings and health 
conditions. It may not stretch to encompass all forms of HIV and ART engagements and 
disengagements throughout the pandemic. 
 
CONCLUSION 
Theories of patient citizenship both herald and critique the concept of ‘cascade of care’ and its 
components.  The progression of the cascade of care can be seen to represent a clear pathway to 
HIV biological citizenship, with viral suppression projected as the objective measurement of success 
and hope of HIV citizens. Multiple constituents of biological citizenship are implicated in the care 
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engagement pivotal to the cascade, including informational citizenship, patient rights, and moral 
values surrounding responsibilisation.  
Our synthesis suggests that further research about emerging forms of patient citizenship linked to 
care and pharmaceutical demands would be greatly relevant in the context of competition for public 
funding and expenditures. Citizenship theories may also need to be ‘tested’ with empirical studies 
regarding rationing and treatment reductions, at a time when engagement and retention in care is 
increasingly articulated along the lines of cost effectiveness debates in health systems (Nosyk et al., 
2014; Stover et al., 2014). Furthermore, as well as their health benefits, the added prevention effects 
of HIV viral suppression also represent significant cost savings (Gupta, Williams and Montaner, 
2014). Against this background, it will be important to analyse how biological citizens may be 
increasingly made individually responsible for more than their own health. 
Viral suppression and related biomarkers are a universally recognised language in biomedicine 
(Flowers, 2010), which lends this clinical information certain capital (Nguyen, 2005). The ‘biological 
efficacy’ of a clinic in retaining patient cohorts on treatment (Nguyen, 2005, p. 139) is intertwined 
with collective evidence of the functioning of national health systems. The notion of biological 
efficacy is thus useful and relevant to analyses of care cascade frameworks, since these are already 
in use to track and model national epidemics and to inform further investment in treatment-as-
prevention strategies in different regions. The literature reviewed here cautions that steps in the 
cascade, which are becoming globally recognisable characteristics, can obfuscate stark structural 
inequalities, pay insufficient attention to local context, and describe little of the linkage between 
initiatives that can achieve potentially more meaningful health outcomes for people living with HIV 
and their broader health needs and rights. 
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 Table 1  Core theoretical papers 
 Authors Year Title 
1 Nguyen, V.-K. 2005 Antiretroviral globalism, biopolitics and therapeutic citizenship 
2 Nguyen, V.-K. 2009 
Government-by-exception: enrolment and experimentality in mass HIV treatment 
programmes in Africa 
3 Nguyen, V.-K. 2010 The republic of therapy: triage and sovereignty in West Africa’s time of AIDS 
4 Nguyen, V.-K. 2013 Counselling against HIV in Africa: a genealogy of confessional technologies 
5 Nguyen, et al. 2007 
Adherence as therapeutic citizenship: impact of the history of access to antiretroviral 
drugs on adherence to treatment 
6 Rabinow, P. 1992a Artificiality and enlightenment: from sociobiology to biosociality 
7 Rabinow, P. 1992b Studies in the anthropology of reason 
8 Petersen, et al. 2010 Healthy living and citizenship: an overview 
9 
Rose, N. & Novas, 
C. 
2005 Biological citizenship 
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 Table 2 Synthesised 
papers 
  
 Authors Country Aims Participants 
1 Alcano, 2009 Italy  Ethnography of HIV clinic in Milan (2007-
2008); 
 Examines relations between 
biotechnologies and work. 
7 male construction workers living 
with HIV (LWH) in Milan. 
2 Biehl, 2007 Brazil Ethnography of Brazilian AIDS policy, ART and 
survival amongst urban poor and marginalised 
populations. 
Policymakers, clinicians, workers, 
patients and members of State and 
NGO treatment and support 
organisations.  
3 Beckmann, 2013 Tanzania  Ethnography of ARV roll-out in Tanzania 
and Zanzibar (2 years);  
 Looks at the promotion of ideas of 
responsibility and self-care in donor AIDS 
intervention programmes. 
 People living with HIV (PLWH): in 
clinics; in support groups; at 
home;  
 Life histories and observation of 
public discussions about HIV. 
4 Bernays and 
Rhodes, 2009 
Serbia and 
Montenegro 
 Qualitative study; 
 Looks at the impact of fragile ART 
delivery in Serbia & Montenegro. 
 41 PLWH in three waves of 
recruitment;  
 18 service providers. 
5 Cataldo, 2008 Brazil  Ethnography in Rio de Janeiro; 
 Explores the ‘public health rhetoric of 
universalism’ from the perspective of the 
urban poor  
Favela inhabitants LWH; health care 
team at local health centre; two HIV 
NGOs. 
6 Colvin et al., 
2010 
South Africa  Ethnography of the Khululeka support 
group for men LWH; 
 Explores citizenship, subjectivity and 
masculinity in the context of HIV 
 Group members and NGO 
workers in Gugulethu (Cape 
Town).  
 No info on number of pts.  
7 Doyal, 2013 n/a  Book focuses on commonalities, 
differences and inequalities in the 
pandemic using narratives of PLWH.  
 Chapter charts issues related to 
treatment.  
n/a  
8 Flowers, 2010 UK Two qualitative studies re-focusing on the 
psychosocial issues of PLWH. 
 Interviews with PLWH in the UK; 
 In 2001 and 2006 using IPA;  
 No detail on size of samples. 
9 Kagee et al., 
2014 
South Africa Contextualises adherence in political and 
historical developments of resource-
constrained countries. 
 Historical and political 
examination of ART provision 
and adherence in SA.  
 No empirical data. 
10 Kistner, 2009 South Africa Discusses the limits and contradictions of 
biological citizenship analysis of SA treatment 
activism and HIV care systems. 
n/a 
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11 Levy and 
Storeng, 2007 
South Africa  Ethnographic fieldwork in Cape Town 
and surrounding area;  
 Explores the meaning of ‘living 
positively’ for women LWH.  
 12 women LWH; 11 HIV 
counsellors; 12 public health 
researchers; policy-makers and 
people involved in voluntary 
orgs; 2 healthcare providers;  
 Observation in support group 
meetings; conferences; policy 
meetings. 
 
12 Marsland, 2012 Tanzania Ethnography looking at experiences of living 
with HIV and ART with families in the district 
of Kyela. 
12 families affected by HIV. 
13 Mattes, 2011 Tanzania  Ethnographic fieldwork (11 months) in 
Tanga; 
 Investigates ‘techniques used to produce 
treatment adherence during treatment 
preparation’ in post ARV roll-out. 
 Main hospital, five health 
centres; observation in VCT 
settings, education sessions, 
clinic consultation and hospital 
floors;  
 27 interviews with providers and 
26 with patients;  
 Observation in support groups, 
focus groups, and at home. 
14 Mattes, 2012 Tanzania  (Study same as above); 
 Discusses how ‘patients’ practices and 
ideas regarding ART are related to 
morality. 
(Same as above); focuses on the case 
study of one man and his family. 
15 Mazanderani 
and Paparini, 
2015 
UK  Joint re-analysis of two qualitative 
datasets; 
 Focuses on questions of normalisation of 
HIV; 
 And on the role of research interviews in 
this process.  
 One study with 35 PLWH;  
 And the other with 41 African 
women LWH;  
 Both in the UK 
16 Meinert et al., 
2009 
Uganda  Ethnography in Kampala and South-
eastern Uganda;  
 Explores CD4 counts as a social 
technology, different ART provision and 
CD4 count services, and how people 
appropriate these. 
48 men and women LWH, accessing 
ART and HIV care through 7 different 
programmes.  
17 Mfecane, 2011 South Africa  Ethnography in Bushbuckridge; 
 Explores the experience of ARV usage 
and support group attendance in a rural 
health facility. 
 25 men interviewed one-to-one;  
 Attending support groups for 14 
months; 
 Engaging with public discussions 
about HIV. 
18 Moyer, 2014 Kenya  Ethnography of Kenyatta National 
Hospital (2011-2014) in Nairobi;  
 Focuses on peer mentors but as part of 
broader and longer-term ethnography in 
the country.  
 
 10 HIV peer mentors in daily 
clinical and peer-group practice;  
 Nurses, social workers, 
administrators and doctors. 
19 Niehaus, 2014 South Africa  Ethnography in Mpumalanga Province; 
 Explores how ART intersects with 
broader national situation and history 
and local village factors in relation to 
uptake.  
 Presents the in-depth case of one man 
LWH. 
 87 households; 
 Individual interviews and 
biographies of 25 men (four 
LWH). 
20 O’Daniel, 2014 USA (North 
Carolina) 
 Ethnography of a federally-funded 
HIV/AIDS service organisation in 
Midway; 
 Explores how low-income African-
American women LWH engage with 
laboratory results and clinical 
understandings of HIV. 
 40 African-American women 
LWH;  
 And 11 providers. 
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21 Persson and 
Newman, 2006 
Australia  Qualitative study on side effects of ART; 
 Explores how self is constituted in the 
context of strength and immunity;  
 Focuses on efavirenz.  
40 PLWH with past/present ART and 
past/present side-effects. 
 
 
22 Rhodes and 
Sarang, 2012 
 
Russia  Qualitative study; 
 Explores factors that impact conditional 
access to ART among people who inject 
drugs in a city with high HIV prevalence. 
 42 people who inject drugs who 
are LWH; 
 And 11 health practitioners. 
23 Robins, 2005 UK and South Africa  Compares the relationship between the 
advent of ART and activism in the UK and 
South Africa;  
 and how new social movements shape 
identities.  
 Limited information;  
 Observation and interviews with 
positive activists and 
organisation members in UK and 
South Africa. 
24 Russell et al., 
2015 
Uganda  Qualitative study; 
 Explores ideas of self-management, and 
the role of healthcare workers and peer 
support groups in shaping treatment 
experience 
Two waves of interviews with 38 
participants LWH.  
25 Squire, 2010 UK and South Africa  Two qualitative studies; 
 Explores the ‘naturalization’ of HIV 
through medicalisation, normalisation 
and marketization processes in different 
local epidemics. 
 In the UK (with 55 PLWH); 
 And South Africa (with 37 
PLWH). 
26 Thomas, 
Aggleton and 
Anderson, 2010 
UK  Part of qualitative study on use of 
alternative medicines by PLWH; 
 Explores communication and meaning-
making in the clinic. 
 
 79 PLWH focus groups; 
 And 20 interviews; 
 All with migrants from Southern 
Africa LWH. 
27 Whyte et al., 
2013 
Uganda Ethnography of the experiences of people on 
ART from the first generation of ARV roll-out 
in Kampala and Eastern Uganda (2005-2007). 
48 PLWH from 7 health centres. 
28 Ware et al., 2009 Nigeria, Tanzania 
and Uganda 
 Ethnographic study in three 
countries; 
 Explores views on adherence from 
perspective of patients, treatment 
partners and health care providers; 
 With particular attention to 
obstacles and facilitators of 
adherence.  
 158 PLWH  
 45 treatment partners (TPs)  
 49 health care providers across 
three hospital sites in the three 
countries (for a total of 414 
interviews);  
 136 sessions of observations in 
the field (clinic visits, counselling 
sessions, health education 
sessions, medication dispensing). 
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BOX 1 
Deflecting biomedicine 
(1) One of the HIV doctors in Alcano’s ethnography in Milan says: ‘a strong patient’ is ‘a patient who complies with 
prescriptions, who takes the medicines methodically’ (2009, p. 121). One of his patients, a positive male construction 
worker, asserts instead: ‘My doctor always repeats that I have to stay strong and take the medicine. I tried to explain 
to him that what makes me strong kind of kills me at work’ (Alcano, 2009, p. 125). 
Situated rationality of ART and adherence 
(2) As the primary provider of the household, Paolo – a construction worker from Milan – feels that ART side-effects 
clash with his primary necessities: ‘I have a family to support and my wife does not have a job. I need to go to work 
and provide for basically everything. And when you are in my situation your arms better be strong and working, 
otherwise you’re in trouble’ (Alcano, 2009, p. 127). 
(3) Leo – another construction worker in Alcano’s ethnography in Milan – describes his ‘steering’ strategies about 
treatment-taking as: ‘getting comfortable in the space between myself and my doctors’ (Alcano, 2009, p. 124). 
Non-engagement 
(4) When asked what their latest blood tests say, participants in O’Daniel’s ethnography with African-American 
women living with HIV in the US reply: ‘I don’t know as far as number wise’; or: ‘she checked my levels but I don’t 
really know where they are now’, adding that: ‘On the weekend I really don’t [take ARVs], but Monday through Friday 
I usually get up and pop them. But as long as I feel good and I’m taking my medicine most of the time, I know that it 
can’t be that bad’ (O’Daniel, 2014, p. 331). 
Case study of competing priorities 
(5) Mattes’ (2011) case study is the story of Haruna, an HIV positive male construction worker in Tanga (Tanzania) 
recently widowed. He is concerned his in-laws will refuse to contribute to the medical care of his new-born son if he 
discloses the mother’s death due to HIV and his own HIV status. Haruna’s need for both treatment and support is 
impossibly balanced, he cannot “harmonize the rigid treatment regime with his working conditions” (p. 170) but also 
has to disclose and “risk his relatives’ solidarity... to ensure adequate medical care for his new-born son” (p. 171).  
Treatment literacy and expertise 
(6) ‘I believe that if you are talking to someone who is educated medically, they won’t understand – ‘you are using 
herbs, what do you need to use herbs for?’ So I thought they wouldn’t understand why I wanted to use the herbs... So 
that’s why I didn’t tell them’ (Zimbabwean participant in Thomas, Aggleton and Anderson, 2010, p. 740). 
Blood counts as truth telling 
(7) As Lady E, one of the positive African American women in O’Daniel’s ethnography in North Carolina (US), 
explains: ‘That’s on you to care about taking those meds. Let’s keep it real. Just call it whatever the hell it really is – 
‘lazy’ or ‘don’t give a damn’. This is the truth of your life. Take the medication or don’t... they’ll know because they 
[doctors’] read it [the truth] in your blood’ (2014, p. 328). 
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BOX 2 
Insecurity and disengagement  
(8) As expressed here by Edilson, one of Cataldo’s (2008) Brazilian 
participants: ‘I am afraid that we could be in a situation where treatment is 
not available any more, and if there is a lack of treatment it would be fatal, 
death would be the only outcome . . . I’m scared, because I have seen many 
weaknesses in the government, and I’m scared that it could be another 
failure’ (p. 908). 
(9) Insecure availability of ART means participants in Bernays and Rhodes’ 
(2009) qualitative study in Serbia and Montenegro discuss how they ‘have 
constantly the worry about what happens today and after today’, ‘live from 
one day to another’, and complain that: ‘the talk with people and in the 
media is always these terrifying headlines, like: ‘there won’t be any 
medicines’; or ‘there won’t be enough money for HIV treatment’ (p. 317). 
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BOX 3 
Returning to sociality 
(10) Maria, a participant in Marsland’s (2012) 
ethnography in rural Tanzania, states: ‘until there 
is some kind of profit in living openly with HIV, I 
am going to keep it a secret’ (2012, p. 470; also 
echoed by participants in Mfecane, 2011 in South 
Africa). 
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